Entero Therapeutics
Why Robinhood?
You can watch ENTO and buy or sell other stocks, ETFs, and their options commission-free!About ENTO
GridAI Technologies Corp. is a diversified technology and life sciences company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.
ENTO Key Statistics
Stock Snapshot
As of today, Entero Therapeutics(ENTO) shares are valued at $4.78. The company's market cap stands at 29.2M, with a P/E ratio of -1.02.
Entero Therapeutics(ENTO) stock opened on 2026-07-25 at —. The price climbed to — and dipped to —.
The Entero Therapeutics(ENTO)'s current trading volume is 0, compared to an average daily volume of 60.65K.
During the past year, Entero Therapeutics(ENTO) stock moved between $1.08 at its lowest and $6.93 at its peak.
During the past year, Entero Therapeutics(ENTO) stock moved between $1.08 at its lowest and $6.93 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.